Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “PET Positive”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00602043
What this trial is testing

F-18 16 Alpha-Fluoroestradiol-Labeled Positron Emission Tomography in Predicting Response to First-Line Hormone Therapy in Patients With Stage IV Breast Cancer

Who this might be right for
Estrogen Receptor-positive Breast CancerProgesterone Receptor-negative Breast CancerProgesterone Receptor-positive Breast Cancer+2 more
National Cancer Institute (NCI) 20
Testing effectiveness (Phase 2)Study completedNCT03212170
What this trial is testing

FFNP-PET/MR Imaging of Progesterone Receptor Expression in Invasive Breast Cancer

Who this might be right for
Invasive Breast Cancer
University of Wisconsin, Madison 21
Not applicableEnrolling By InvitationNCT07162779
What this trial is testing

Evaluation of [68Ga]DOTA-IR-780-C-4 in PET Imaging Studies for PSMA-Positive Prostate Cancer Patients

Who this might be right for
PET CT
Affiliated Hospital of Jiangnan University 5
Not applicableLooking for participantsNCT04281641
What this trial is testing

Markers to Evaluate the Efficacy of PH-based Regimen as a Neoadjuvant Therapy for Operable HER2 Positive Breast Cancer

Who this might be right for
HER2-positive Breast Cancer
Fudan University 94
Not applicableUnknownNCT04128631
What this trial is testing

Thyroid Cancer and (FDG)PET/CT Scan

Who this might be right for
Thyroid Cancer
Assiut University 35
Not applicableStudy completedNCT05609552
What this trial is testing

Biodistribution and Pharmacokinetics of Pretomanid in Tuberculosis Patients Using 18F-Pretomanid PET

Who this might be right for
Tuberculosis
Johns Hopkins University 10
Testing effectiveness (Phase 2)Looking for participantsNCT05893381
What this trial is testing

Lu-PSMA and Stereotactic Radiotherapy Versus Radiotherapy Alone for Prostate Cancer (LUST)

Who this might be right for
Prostate Cancer
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS 70
Testing effectiveness (Phase 2)Ended earlyNCT03145857
What this trial is testing

Evaluate a New Way to Identify/Diagnose Tumours With Somatostatin Receptors Using [68]Ga-HA-DOTATATE and to Ensure it is Safe to Use

Who this might be right for
Neuroendocrine Tumors
AHS Cancer Control Alberta 634
Not applicableActive Not RecruitingNCT02116140
What this trial is testing

ASV Effects on Myocardial Energetics and Sympathetic Nerve Function in Heart Failure and Sleep Apnea.

Who this might be right for
Heart FailureObstructive Sleep ApneaCentral Sleep Apnea
Ottawa Heart Institute Research Corporation 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT02827877
What this trial is testing

Cu64-DOTA-trastuzumab PET and Markers Predicting Response to Neoadjuvant Trastuzumab + Pertuzum in HER2+ Breast Cancer

Who this might be right for
HER2 Positive Breast CarcinomaStage IIIA Breast CancerStage IIIB Breast Cancer+1 more
City of Hope Medical Center 18
Not applicableStudy completedNCT02043444
What this trial is testing

Secretory Azoospermia and FDG (Fluoro Deoxyglucose) PET-CT

Who this might be right for
Fertility
University Hospital, Toulouse 160
Not applicableLooking for participantsNCT06307015
What this trial is testing

De-escalation of Radiation Dose in HPV-associated OPC Utilising FMISO PET (DE-RADIATE)

Who this might be right for
HPV Positive Oropharyngeal Squamous Cell Carcinoma
Royal North Shore Hospital 25
Not applicableStudy completedNCT06655545
What this trial is testing

18F-fluoroestradiol (18F-FES) PET/CT Guided First-line Treatment for HR+/HER2- Metastatic Breast Cancer Patients

Who this might be right for
Breast Cancer
Fudan University 473
Not applicableStudy completedNCT04276272
What this trial is testing

D4 Choline Breast PET/CT

Who this might be right for
HER2-negative Breast CancerER Positive Breast CancerMetastatic Breast Cancer
Imperial College London 6
Not applicableUnknownNCT03655353
What this trial is testing

68Ga-ABY-025 PET for Non-invasive Quantification of HER2-expression in Advanced Breast Cancer

Who this might be right for
HER2-positive Breast Cancer
Henrik Lindman 160
Testing effectiveness (Phase 2)WithdrawnNCT04273555
What this trial is testing

Monitoring Early Response to Targeted Therapy in Stage IV HER2+ Breast Cancer Patients With Advanced PET/MR Imaging

Who this might be right for
HER2-positive Breast Cancer
University of Alabama at Birmingham
Not applicableStudy completedNCT02978586
What this trial is testing

A Pilot Study of [Ga-68]PSMA PET/MRI for the Assessment of PSMA-positive Tumors

Who this might be right for
Prostate-specific Membrane Antigen Positive TumorsProstate CancerBreast Cancer+1 more
Case Comprehensive Cancer Center 8
Not applicableStudy completedNCT01613196
What this trial is testing

Positron Emission Tomography in Extrapulmonary Tuberculosis

Who this might be right for
Extrapulmonary TuberculosisLymph Node TuberculosisBone Tuberculosis
Assistance Publique - Hôpitaux de Paris 55
Not applicableLooking for participantsNCT05873777
What this trial is testing

68Ga-FAPI-LM3 PET/CT Imaging in Patients With FAP/SSTR2 Positive Disease and Compared With 18F-FDG

Who this might be right for
SSTR2FAPPositron-Emission Tomography
The First Affiliated Hospital of Xiamen University 30
Testing effectiveness (Phase 2)Study completedNCT01565200
What this trial is testing

HER2 Imaging Study to Identify HER2 Positive Metastatic Breast Cancer Patient Unlikely to Benefit From T-DM1

Who this might be right for
HER-2 Positive Breast Cancer
Jules Bordet Institute 90
Next Page